Monograph Index A-Z

This index is particularly useful for healthcare professionals, researchers, and individuals seeking detailed information about specific branded pharmaceutical product.

Each of these comprehensive documents serve as essential clinical references and provides detailed information about drug composition, indications, contraindications, dosage forms, and administration guidelines.

Search monograph

You can find product characteristics and informations about a specific drug.

Type the name of a drug in the search filed below:

Alternatively, look up drug monographs alphabetically by selecting a letter:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Starting with M

Title
Information Source
Document Type
 
MAALOX Oral suspension
Health Products Regulatory Authority (IE)
Summary of Product Characteristics (SPC)
MAALOX PLUS Oral suspension
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MabCampath 30mg/ml concentrate for solution for infusion
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MACI Implantation matrix
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MACRILEN Granule for solution
FDA, National Drug Code (US)
Structured Product Labeling (SPL/PLR)
MACROBID Capsule
FDA, National Drug Code (US)
Structured Product Labeling (SPL)
MACROBID Prolonged-release capsule
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MACRODANTIN Capsule
FDA, National Drug Code (US)
Structured Product Labeling (SPL)
MACUGEN Solution for injection
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MADOPAR Capsule, Rapid dispersible tablet
Medicines and Medical Devices Safety Authority (NZ)
Summary of Product Characteristics (SPC)
MAGNASPARTATE Powder for oral solution
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MAGNESIUM SULFATE 20% w/v Solution for infusion
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MAGNEVIST Solution for injection
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MAGRILAN Hard capsule
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MAGUROL Tablet
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MAINTELYTE Solution for infusion
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MAJOVEN Prolonged-release capsule, hard
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MALARONE Film-coated tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MALARONE PAEDIATRIC Film-coated tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MANERIX Film-coated tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MANIDIPINE Tablet
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MANNITOL Solution for infusion
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MARCAIN HEAVY Solution for injection
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MARCAIN POLYAMP STERIPACK Solution for injection
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MARCAINE Solution for injection
FDA, National Drug Code (US)
Structured Product Labeling (SPL)
MARVELON Tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MATORIDE XR Prolonged-release tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MATRIFEN Transdermal patch
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MATULANE Capsule
FDA, National Drug Code (US)
Structured Product Labeling (SPL)
MAVENCLAD Tablets
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MAVIRET Coated granules
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MAVIRET Film-coated tablet
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MAXALT Tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MAXAQUIN F. C. Tablets
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MAXIDEX Eye drops, suspension
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MAXITROL Eye drops, suspension
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MAXOLON Solution for injection
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MAXOLON Tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MAYZENT Film-coated tablet
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MAYZENT Film-coated tablet
FDA, National Drug Code (US)
Structured Product Labeling (SPL/PLR)
MECLIZINE HYDROCHLORIDE Tablet
FDA, National Drug Code (US)
Structured Product Labeling (SPL/PLR)
MECOLZINE Gastro-resistant tablet
Web Search
Summary of Product Characteristics (SPC)
MECOLZINE Suppository
Web Search
Summary of Product Characteristics (SPC)
MEDABON CO Tablet, Vaginal tablet
Health Products Regulatory Authority (ZA)
Medication Package Insert (MPI)
MEDAPIA Film-coated tablet
Medicines Authority (MT)
Summary of Product Characteristics (SPC)
MEDAXONUM Powder for solution for injection/infusion
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MEDIJEL Oral gel
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MEDIKINET Tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MEDOBETA Cream
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MEDOCEF Powder for solution for injection / infusion
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MEDOCIPRIN Film-coated tablet
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MEDOCLAZIDE Tablet
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MEDOCLOR Hard capsule, Granules for oral suspension
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MEDOCRIPTINE Tablet
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MEDOCYCLINE Hard capsule
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MEDODERMONE Cream
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MEDOFED COMPOUND Oral solution
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MEDOFED Oral solution
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MEDOFLORAN Tablet
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MEDOFLOXINE Film-coated tablet
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MEDOFULVIN Tablet
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MEDOLEXIN Capsule
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MEDOLIN Tablet
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MEDOMYCIN Hard capsule
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MEDOPRAZOLE Gastro-resistant capsule, hard
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MEDOPRED Solution for injection / infusion
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MEDOPRED Tablet
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MEDORIL Capsule
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MEDORPHAN Oral solution
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MEDORPHAN Syrup
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MEDOTRAMOL Film-coated tablet
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MEDOVENT Tablet
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MEDOVIR Cream
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MEDOVIR Powder for solution for infusion
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MEDOVIR Tablet
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MEDROL Tablet
FDA, National Drug Code (US)
Structured Product Labeling (SPL)
MEDRONE Tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MEFENAMIC ACID Oral suspension
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MEGACE Tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MEKINIST Film-coated tablet
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MEKTOVI Film-coated tablet
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MELCAM Tablet
Health Products Regulatory Authority (IE)
Summary of Product Characteristics (SPC)
MELODENE Coated tablet
Health Products Regulatory Authority (ZA)
Medication Package Insert (MPI)
MELOREX Tablet
Medicines and Medical Devices Safety Authority (NZ)
Summary of Product Characteristics (SPC)
MELOX Tablet
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MELOXICAM Orodispersible tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MELPHALAN Film-coated tablets
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MELPHALAN Powder and solvent for solution for injection/infusion
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MENDICOF Syrup
Health Sciences Authority (SG)
Medication Package Insert (MPI)
MENEST Film-coated tablet
FDA, National Drug Code (US)
Structured Product Labeling (SPL)
MENOSTAR Patch
FDA, National Drug Code (US)
Structured Product Labeling (SPL/PLR)
MENTAX Cream
FDA, National Drug Code (US)
Structured Product Labeling (SPL)
MEPACT Powder for concentrate for dispersion for infusion
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MEPROBAMATE Tablet
FDA, National Drug Code (US)
Structured Product Labeling (SPL)
MEPRON Oral suspension
FDA, National Drug Code (US)
Structured Product Labeling (SPL/PLR)
MEPSEVII Concentrate for solution for infusion
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MEPTID Film-coated tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MEPTID Solution for injection
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MEPTIN Tablet
Web Search
Medication Package Insert (MPI)
MERONEM IV 1g Powder for solution for injection or infusion
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MEROPENEM Powder for solution for injection / infusion
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MERREM IV Solution for injection
FDA, National Drug Code (US)
Structured Product Labeling (SPL/PLR)
MESASAL Enteric-coated tablet
Pharmaceutical Benefits Scheme (AU)
Summary of Product Characteristics (SPC)
MESNA Ampoules of aqueous solution
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MESNA Film-coated tablets
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MESTINON Tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MESULID Tablet
Summary of Product Characteristics (SPC)
METAGYL Tablet
Marketing Authorisation Holder
Medication Package Insert (MPI)
METALYSE Powder and solvent for solution for injection
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
METAMIZOLE SODIUM Oral drops, solution
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
METARAMINOL Solution for injection
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
METEOSPASMYL Soft capsule
Marketing Authorisation Holder
Summary of Product Characteristics (SPC)
METFORAL Film-coated tablet
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
METFORMIN Oral Solution
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
METHADOSE Tablet
FDA, National Drug Code (US)
Structured Product Labeling (SPL/PLR)
METHOCARBAMOL NEURAXPHARM Film-coated tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
METHOFILL Solution for injection in pre-filled injector
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
METHOTREXATE Solution for Injection
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
METHOTREXATE Tablets
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
METHYCOBAL Solution for injection
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
METHYCOBAL Tablet
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
METHYLDOPA Film coated tablets
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
METHYLTHIONINIUM CHLORIDE PROVEBLUE Solution for injection
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
METOJECT PEN Solution for injection in pre-filled pen
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
METOPIRONE Capsules
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
METOPROLOL TARTRATE Tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
METOSYN Cream
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
METROGEL Gel
FDA, National Drug Code (US)
Structured Product Labeling (SPL/PLR)
METRONIDAZOLE Film-coated tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
METRONIDAZOLE Solution for infusion
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
METROSA Gel
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
METVIX Cream
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MEZAVANT XL Gastro-resistant, prolonged release tablets
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MIACALCIN Solution for injection
FDA, National Drug Code (US)
Structured Product Labeling (SPL/PLR)
MIANSERIN Film-coated tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MIBI TECHNESCAN Kit for radiopharmaceutical preparation
Health Products Regulatory Authority (IE)
Summary of Product Characteristics (SPC)
MICARDIS Tablet
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MICROGYNON Sugar-coated tablets
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MICROLUT Sugar-coated tablet
Medicines and Medical Devices Safety Authority (NZ)
Summary of Product Characteristics (SPC)
MICROVAL Coated tablet
Web Search
Summary of Product Characteristics (SPC)
MIDAZOLAM Solution for injection or infusion
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MIFEGYNE Tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MIGARD Film-coated tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MIGRANAL Nasal spray
FDA, National Drug Code (US)
Structured Product Labeling (SPL)
MILDRONATS Solution for injection
Summary of Product Characteristics (SPC)
MILK OF MAGNESIA Oral Suspension
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MILNIRONE Solution for injection / infusion
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MIMPARA Film-coated tablet
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MINESSE Film-coated tablet
Health Products Regulatory Authority (ZA)
Medication Package Insert (MPI)
MINIDIAB Tablet
Pharmaceutical Benefits Scheme (AU)
Summary of Product Characteristics (SPC)
MINIMS POVIDONE IODINE Eye drops, solution
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MINIMS PREDNISOLONE Single-use eye drops
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MINIMS PROXYMETACAINE Eye drops, solution
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MINIMS TETRACAINE HYDROCHLORIDE Single-use, sterile eye drops
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MINIPRESS Capsule
FDA, National Drug Code (US)
Structured Product Labeling (SPL)
MINITRAN 5 Adhesive transdermal patch
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MINJUVI Powder for concentrate for solution for infusion
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MINOCIN SA Modified release hard capsule
Health Products Regulatory Authority (IE)
Summary of Product Characteristics (SPC)
MINOCYCLINE Film-coated tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MINODIAB Tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MINORGA Cutaneous solution
Medicines Authority (MT)
Summary of Product Characteristics (SPC)
MIOCHOL-E Powder and solvent for instillation solution
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MIOSTAT Solution for injection
FDA, National Drug Code (US)
Structured Product Labeling (SPL)
MIRAPEX Tablet
FDA, National Drug Code (US)
Structured Product Labeling (SPL/PLR)
MIRAPEXIN Tablet / Prolonged-release tablet
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MIRATON Capsule
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MIRCERA Solution for injection
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MIRELLE Film-coated tablet
Health Products Regulatory Authority (ZA)
Medication Package Insert (MPI)
MIRTAZAPINE Orodispersible tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MIRVASO Gel
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MISYO Concentrate for oral solution
Health Products Regulatory Authority (ZA)
Medication Package Insert (MPI)
MITOMYCIN Powder for solution for injection or infusion
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MITOXANTRONE Concentrate for solution for infusion
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MIVACRON Liquid for injection
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MIZART Tablet
Pharmaceutical Benefits Scheme (AU)
Summary of Product Characteristics (SPC)
MIZOLLEN Modified-release tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MOBIC Tablet
FDA, National Drug Code (US)
Structured Product Labeling (SPL/PLR)
MOBIFLEX Film-coated tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MODALIM Tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MODECATE Solution for injection
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MODERNA COVID-19 VACCINE CX-024414 Suspension for injection
FDA, National Drug Code (US)
Structured Product Labeling (SPL/PLR)
MODIGRAF Granules for oral suspension
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MODURETIC Tablet
Medicines and Medical Devices Safety Authority (NZ)
Summary of Product Characteristics (SPC)
MOEXIPRIL HYDROCHLORIDE Film-coated tablet
FDA, National Drug Code (US)
Structured Product Labeling (SPL)
MOGADON Tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MOLIPAXIN Capsule
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MOMETASONE FUROATE Cream
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MONJUVI Solution for injection
FDA, National Drug Code (US)
Structured Product Labeling (SPL/PLR)
MONKASTA Film-coated tablet
Medicines Authority (MT)
Summary of Product Characteristics (SPC)
MONOCLOX Powder for solution for injection or infusion
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MONOFER Solution for injection / infusion
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MONOFERRIC Solution for injection
FDA, National Drug Code (US)
Structured Product Labeling (SPL/PLR)
MONOPOST Eye drops, solution
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MONOREM Prolonged-release tablet
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MONOREM Tablet
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MONOVER Solution for injection / infusion
Health Products Regulatory Authority (IE)
Summary of Product Characteristics (SPC)
MONOVO Cream
Health Products Regulatory Authority (IE)
Summary of Product Characteristics (SPC)
MONTELUKAST Film-coated tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MONURIL Granules for oral solution
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MONUROL Granules for oral solution
FDA, National Drug Code (US)
Structured Product Labeling (SPL)
MORPHGESIC Controlled release tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MORPHINE SULFATE Solution for injection
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MOTETIS Tablet
Medicines and Medical Devices Safety Authority (NZ)
Summary of Product Characteristics (SPC)
MOTIFENE Capsule, hard
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MOTIFINE Capsule, hard
Health Products Regulatory Authority (ZA)
Medication Package Insert (MPI)
MOTILIUM Film-coated tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MOTRIN Tablet
Health Products and Food Branch (CA)
Structured Product Monograph (SPM)
MOUNJARO Solution for injection
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MOVANTIK Film-coated tablet
FDA, National Drug Code (US)
Structured Product Labeling (SPL/PLR)
MOVENTIG Film-coated tablet
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MOVIPREP Oral solution
FDA, National Drug Code (US)
Structured Product Labeling (SPL/PLR)
MOXARIN Capsule, hard
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MOXICAM Tablet
Summary of Product Characteristics (SPC)
MOXILEN Capsule, Powder for oral suspension, Powder for solution for injection
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MOXIVIG Eye drops
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MOXONIDINE Film-coated tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MOZOBIL Solution for injection
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MS CONTIN Tablet
FDA, National Drug Code (US)
Structured Product Labeling (SPL/PLR)
MST CONTINUS Prolonged release granules for oral suspension
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MST CONTINUS Prolonged-release tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MUCOBROXOL Syrup
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MUCODYNE Capsule, hard
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MUCODYNE Syrup
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MUCOSOLV Capsule
Health Products Regulatory Authority (ZA)
Medication Package Insert (MPI)
MUCOSTA Tablet
Web Search
Medication Package Insert (MPI)
MULPLEO Film-coated tablet
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MULTAQ Film-coated tablets
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MULTIBIC Solution for haemodialysis/haemofiltration
Marketing Authorisation Holder
Summary of Product Characteristics (SPC)
MULTIHANCE Solution for injection
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MUNTEL Film-coated tablet
Health Products Regulatory Authority (IE)
Summary of Product Characteristics (SPC)
MURINE IRRITATION & REDNESS RELIEF
Health Products Regulatory Authority (IE)
Summary of Product Characteristics (SPC)
MURIPOCIN 2% w/w Ointment
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MUSE Urethral Stick
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MVABEA Suspension for injection
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MYALEPTA Powder for solution for injection
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MYAMBUTOL Film-coated tablet
FDA, National Drug Code (US)
Structured Product Labeling (SPL)
MYBULEN Capsule
Health Products Regulatory Authority (ZA)
Medication Package Insert (MPI)
MYCAMINE Powder for solution for infusion
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MYCAPSSA Gastro-resistant hard capsule
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MYCLAUSEN Film-coated tablet
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MYCOBUTIN Capsules
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MYCOKEM 500 Film-coated tablet
Pharmaceutical Benefits Scheme (AU)
Summary of Product Characteristics (SPC)
MYCORIL Vaginal tablet
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MYCOSTATIN Oral suspension
Health Products Regulatory Authority (IE)
Summary of Product Characteristics (SPC)
MYDFRIN 2.5% w/v Ophthalmic solution
Health Products and Food Branch (CA)
Structured Product Monograph (SPM)
MYDOFLEX Film-coated tablet
Υπουργείο Υγείας (CY)
Summary of Product Characteristics (SPC)
MYDRIACYL Eye drops, solution
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MYDRILATE 1.0% Eye drops
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MYFORTIC Gastro-resistant tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MYKRONOR Solution for injection / infusion
Health Products Regulatory Authority (IE)
Summary of Product Characteristics (SPC)
MYLATAF Film-coated tablet
Health Products Regulatory Authority (ZA)
Medication Package Insert (MPI)
MYLERAN Film-coated tablet
FDA, National Drug Code (US)
Structured Product Labeling (SPL)
MYLOTARG Powder for concentrate for solution for infusion
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MYONAL Tablets / Granules
Structured Product Labeling (SPL/PLR)
MYOPRIDIN Tablet
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MYOVIEW Kit, Powder for solution for injection
FDA, National Drug Code (US)
Structured Product Labeling (SPL/PLR)
Myozyme 50 mg, powder for concentrate for solution for infusion
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MYOZYME Powder for concentrate solution
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MYRELEZ Solution for injection
Health Products Regulatory Authority (IE)
Summary of Product Characteristics (SPC)
MYSILDECARD Film-coated tablet
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MYSIMBA Prolonged-release tablet
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
MYSODELLE Vaginal delivery system
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)
MYSOLINE Tablet
FDA, National Drug Code (US)
Structured Product Labeling (SPL)
MYTESI Delayed-release tablet
FDA, National Drug Code (US)
Structured Product Labeling (SPL/PLR)

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈